Gentian’s CEO Dr Hilja Ibert, PhD, joined BioTalk host Rich Bendis, Founder, President and CEO BioHealth Innovation Inc. at the Capital Region Investor Conference last week. In this podcast Dr Ibert talks about Gentian’s presence in the US market, biomarkers and how Gentian focuses on innovating diagnostic efficiency.
Gentian’s subsidiary in the US, Gentian USA, Inc. collaborates with BioHealth Innovation (BHI) in order to expand Gentian’s presence in the USA. BHI is an innovation intermediary that translates relevant market research into commercial success by connecting management, funding, and markets. The collaboration allows Gentian to support current and new US customers and OEM partners more closely, and will also make Gentian's products more visible to a larger US customer base.